ConCallIQ
Go Pro
Home › Glenmark Pharmaceuticals › PAT History

Glenmark Pharmaceuticals PAT History — Quarter by Quarter

Glenmark Pharmaceuticals's pat moved from ₹47 Cr in Q1 FY26 to ₹403 Cr in Q3 FY26, a 757.4% change over 3 quarters. The table keeps each quarter linked back to the underlying earnings page.

PAT by Quarter

QuarterPAT (₹ Cr)YoY Change
Q3 FY26₹403 Cr—
Q2 FY26₹610 Cr—
Q1 FY26₹47 Cr—

What management said about pat

G

Q1 FY26 · Europe and emerging markets to return to double-digit growth in FY26

Europe region expected to return to double-digit growth from Q2 onwards, and emerging markets anticipated to grow double-digit on constant currency basis in FY26.